Surprisingly, anti-NKG2A antibody reduced IL-22 production by T1D mouse liver cells (108.29±5.05 to 66.05±18.15; p<0.001, ANOVA test; Fig. 5d). This evidence concerns the gene KLRC1 and type 1 diabetes mellitus.